Global Taxanes Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Taxanes Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Taxane drugs are a series of derivatives synthesized by isolating anti-tumor active ingredients from plants and modifying the structure of the compounds of the active ingredients. They are mainly used in the field of chemotherapy for cancer treatment. Taxane drugs mainly include paclitaxel and its modified preparations, docetaxel and its modified preparations, cabazitaxel and derivatives with a taxane skeleton structure.
Taxanes report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Taxanes market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Ovarian Cancer and Breast Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Taxanes industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Taxanes key manufacturers include Bristol Myers Squibb, Sanofi, Celgene Corporation, Pfizer, Biological E., Taj Accura, Khandeiwal Laboratories, Jiangsu Chia Tai-Tianqing Pharmaceutical and Nanjing Sike Medicine Industry, etc. Bristol Myers Squibb, Sanofi, Celgene Corporation are top 3 players and held % sales share in total in 2022.
Taxanes can be divided into Paclitaxel, Docetaxel, Cabazitaxel and Taxane Derivatives, etc. Paclitaxel is the mainstream product in the market, accounting for % sales share globally in 2022.
Taxanes is widely used in various fields, such as Ovarian Cancer, Breast Cancer, Non-small Cell Lung Cancer and Others, etc. Ovarian Cancer provides greatest supports to the Taxanes industry development. In 2022, global % sales of Taxanes went into Ovarian Cancer filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Taxanes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Bristol Myers Squibb
Sanofi
Celgene Corporation
Pfizer
Biological E.
Taj Accura
Khandeiwal Laboratories
Jiangsu Chia Tai-Tianqing Pharmaceutical
Nanjing Sike Medicine Industry
Shanghai Yizhong Pharmaceutical
QILU Pharmaceutical
Segment by Type
Paclitaxel
Docetaxel
Cabazitaxel
Taxane Derivatives
Others
Ovarian Cancer
Breast Cancer
Non-small Cell Lung Cancer
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Taxanes market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Taxanes, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Taxanes industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Taxanes in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Taxanes introduction, etc. Taxanes Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Taxanes market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Taxanes report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Taxanes market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Ovarian Cancer and Breast Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Taxanes industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Taxanes key manufacturers include Bristol Myers Squibb, Sanofi, Celgene Corporation, Pfizer, Biological E., Taj Accura, Khandeiwal Laboratories, Jiangsu Chia Tai-Tianqing Pharmaceutical and Nanjing Sike Medicine Industry, etc. Bristol Myers Squibb, Sanofi, Celgene Corporation are top 3 players and held % sales share in total in 2022.
Taxanes can be divided into Paclitaxel, Docetaxel, Cabazitaxel and Taxane Derivatives, etc. Paclitaxel is the mainstream product in the market, accounting for % sales share globally in 2022.
Taxanes is widely used in various fields, such as Ovarian Cancer, Breast Cancer, Non-small Cell Lung Cancer and Others, etc. Ovarian Cancer provides greatest supports to the Taxanes industry development. In 2022, global % sales of Taxanes went into Ovarian Cancer filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Taxanes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Bristol Myers Squibb
Sanofi
Celgene Corporation
Pfizer
Biological E.
Taj Accura
Khandeiwal Laboratories
Jiangsu Chia Tai-Tianqing Pharmaceutical
Nanjing Sike Medicine Industry
Shanghai Yizhong Pharmaceutical
QILU Pharmaceutical
Segment by Type
Paclitaxel
Docetaxel
Cabazitaxel
Taxane Derivatives
Others
Segment by Application
Ovarian Cancer
Breast Cancer
Non-small Cell Lung Cancer
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Taxanes market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Taxanes, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Taxanes industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Taxanes in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Taxanes introduction, etc. Taxanes Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Taxanes market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
